Akebia Therapeutics (AKBA) Interest & Investment Income (2015 - 2017)
Akebia Therapeutics' Interest & Investment Income was $842,000 in Q3 2017, up 284.5% from $219,000 a year earlier and up 38.5% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Interest & Investment Income (2015 - 2017) Analysis & Trends
On a trailing twelve-month basis, Akebia Therapeutics' Interest & Investment Income was $2.06 million through Sep 30, 2017, up 133.7% year-over-year; for FY2016, it was $901,000, up 76.7% from FY2015.
- In earlier years, Interest & Investment Income was $510,000 in FY2015 (+147.6%) and $206,000 in FY2014.
- The Q3 2017 figure marks the highest quarterly Interest & Investment Income in data going back to Q2 2015.
- Compared with a year earlier, Interest & Investment Income has increased for six straight quarters, with growth averaging 116.3% over the last six quarters.
- Per Business Quant data, AKBA's Interest & Investment Income in the three quarters before Q3 2017 was $608,000 (Q2 2017), $435,000 (Q1 2017) and $179,000 (Q4 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 842,000.00 |
| Jun 30, 2017 | 608,000.00 |
| Mar 31, 2017 | 435,000.00 |
| Dec 31, 2016 | 179,000.00 |
| Sep 30, 2016 | 219,000.00 |
| Jun 30, 2016 | 270,000.00 |
| Mar 31, 2016 | 234,000.00 |
| Dec 31, 2015 | 160,000.00 |
| Sep 30, 2015 | 139,000.00 |
| Jun 30, 2015 | 116,000.00 |
API Access
Akebia Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();